KFBIO AI Cervical Cancer Screening Solution Supports Digital Pathology Innovation

KFBIO Showcases AI Solutions at China’s Leading Maternal and Child Health Conference

On December 23–24, KFBIO participated in the 12th China Maternal and Child Health Conference. The conference was organized by the China Maternal and Child Health Association. It was held at the Fuzhou Strait International Conference & Exhibition Center.

As one of China’s leading maternal and child health events, the conference attracted healthcare experts and institutions from across the country. During the event, KFBIO presented its AI-powered cervical cancer screening solution and end-to-end digital pathology platform. These solutions attracted strong interest from healthcare institutions, pathology experts, and regional partners.

Supporting High-Quality Maternal and Child Healthcare

In 2021, China continued to promote its national maternal and child health plan. As a result, experts and scholars from across the country gathered to discuss future healthcare development. The conference focused on several important topics. These included healthcare reform, policy development, information management, talent training, specialty development, digital pathology, and technological innovation. Together, these discussions aimed to improve the quality of maternal and child healthcare across China.

Comprehensive Digital Pathology Solutions

At the conference, Ningbo Konfoong Bioinformation Tech Co., Ltd. (KFBIO) demonstrated its comprehensive digital pathology solutions. The company also introduced its AI-assisted cervical cancer screening system. These technologies attracted significant attention from maternal and child healthcare institutions and regional distributors. Many visitors highly recognized the quality of KFBIO’s products. They also expressed confidence in the future of digital pathology for maternal and child healthcare.

AI-Driven Cervical Cancer Screening Supports Better Healthcare

Cervical cancer remains a major public health challenge. However, many healthcare institutions still face several difficulties. These challenges include limited screening coverage, a shortage of cytopathologists, low screening efficiency, and inconsistent quality control. To address these issues, KFBIO has developed an AI-assisted pathology solution. The solution supports the entire cervical cancer screening workflow. It combines advanced digital pathology technologies with artificial intelligence.

As a result, healthcare institutions can improve screening efficiency, strengthen quality control, and provide more consistent diagnostic services.

The complete solution includes:

• Gynecological sample collection
• Slide preparation and staining
• Digital slide scanning
• AI-powered image analysis
• Manual review by pathologists
• Report generation

This integrated workflow helps maternal and child healthcare institutions improve both diagnostic quality and operational efficiency.

A Complete AI-Powered Cervical Cancer Screening Workflow

KFBIO provides a complete digital pathology workflow for cervical cancer screening. The solution covers every step, from sample collection to final diagnosis. As a result, laboratories can improve efficiency, strengthen quality control, and deliver more consistent results.

1. Standardized Sample Collection and Tracking

KFBIO developed its own liquid-based cytology (LBC) sampling kit. Healthcare providers can scan a barcode with a terminal device during sample collection. The system automatically links sample information to the provincial health platform. As a result, every sample can be tracked throughout the entire workflow.

In addition, the system supports standardized collection and real-time quality control from the very beginning. This process helps reduce manual errors and improves data accuracy.

2. High-Quality Slide Preparation and Staining

High-quality slides are essential for accurate diagnosis. Therefore, KFBIO uses advanced natural sedimentation technology together with automated staining systems. These technologies effectively remove blood, mucus, and other interfering substances. As a result, laboratories can produce clean and consistent slides. Better slide quality also improves positive detection rates and provides a stronger foundation for AI analysis.

3. High-Throughput Digital Slide Scanning

After slide preparation, the samples are digitized using the KF-PRO-400 High-Throughput Digital Slide Scanner. The scanner uses advanced line-scanning technology to capture high-resolution whole-slide images. As a result, laboratories can digitize large numbers of slides quickly and efficiently. The digital images support slide review, long-term storage, retrospective analysis, and quality management. In addition, digital workflows make collaboration between laboratories and pathologists much easier.

4. Accurate AI-Powered Analysis

Once the slides are digitized, the AI analysis system automatically begins image evaluation. The system uses a deep learning neural network (DNN). It has been trained with large numbers of annotations from experienced pathologists. As a result, the AI can automatically identify suspected lesion areas with high sensitivity and specificity. The system also provides stable and consistent screening results.

Meanwhile, pathologists can focus on reviewing suspicious cases instead of screening every slide manually. This approach improves both efficiency and diagnostic consistency.

5. Smarter Review and Report Generation

After AI analysis, pathologists review the suspected cases identified by the system. They can quickly verify abnormal cells and complete the final diagnosis. The system then supports report generation and case management.

As a result, the entire workflow becomes faster, more standardized, and easier to manage. By combining AI with expert review, KFBIO helps healthcare institutions improve both efficiency and diagnostic quality.

Why This Workflow Matters

KFBIO’s integrated workflow connects every stage of cervical cancer screening into one digital platform. Instead of relying on separate systems, laboratories can manage the entire process more efficiently. In addition, standardized digital workflows improve data quality and support better clinical decision-making.

As healthcare institutions continue their digital transformation, this solution helps them build a more efficient, accurate, and scalable pathology service.

AI Improves Screening Efficiency and Diagnostic Accuracy

KFBIO’s AI analysis system is powered by a deep learning neural network (DNN). The algorithm has been trained with annotations from experienced pathologists. As a result, it can accurately identify suspected lesion areas with high sensitivity and specificity.

The system achieves a negative exclusion rate of more than 60%. It also delivers a positive detection rate of up to 98%. These results significantly reduce the workload of primary screening in hospitals. Instead of reviewing every slide, pathologists can focus on cases flagged by the AI system.As a result, diagnostic efficiency improves while maintaining high accuracy and consistency.

In addition, AI-assisted screening supports more standardized pathology workflows across different healthcare institutions.

Driving Innovation in Maternal and Child Pathology

As a leading provider of end-to-end digital pathology solutions, KFBIO remains committed to continuous innovation. We combine artificial intelligence, digital pathology, and remote consultation technologies into one integrated platform. This approach helps healthcare institutions improve diagnostic efficiency and optimize clinical workflows.

Meanwhile, our solutions support more standardized pathology practices and better quality management. As digital transformation continues, KFBIO will keep developing innovative technologies for pathology laboratories. We are committed to helping healthcare providers deliver faster, more accurate, and more accessible diagnostic services.

Ultimately, our goal is to support the long-term development of maternal and child pathology. We also strive to improve the health and well-being of women and children through advanced digital pathology solutions.

Learn More About KFBIO Digital Pathology Solutions

KFBIO provides comprehensive digital pathology solutions for hospitals, laboratories, and research institutions.

Our portfolio includes:

• Digital pathology scanners
• AI-assisted pathology solutions
• Cervical cancer screening systems
• Pathology Information Management System (PIMS)
• Remote pathology consultation platforms
• Whole-slide imaging (WSI) solutions

Whether you are building a new digital pathology laboratory or upgrading an existing workflow, KFBIO is ready to support your digital transformation.

To learn more about our products and solutions, please visit our website or contact our team.